Blue Chip Capital Group, Inc. announced on November 12, 2026, that its Common Stock has been approved for quotation on the OTCID Basic Market of OTC Markets. As of November 12, 2026, the stock was quoted at $0.90 per share. The OTCID is a trading market for companies that meet a minimal current information standard and provide management certification, distinct from the OTCQB Venture Market, which requires stricter qualitative standards.
The Company believes it meets the qualification requirements for uplisting to the OTCQB Venture Market. These requirements include being current in SEC reporting obligations, filing audited financial statements for each year since becoming obligated to report, having at least 51 shareholders who own an aggregate of 25,548,246 unrestricted shares representing approximately 23.5% of the total outstanding shares, and utilizing an SEC-registered transfer agent that participates in the Transfer Agent Verified Shares Program.
However, the Company has not yet met the minimum bid price requirement for OTCQB admission. To qualify, the stock must have a minimum bid price of $0.05 per share for 30 consecutive calendar days immediately preceding admission. The Company’s Common Stock only obtained DTC Eligibility on November 6, 2026, and as of November 10, 2026, 4,825,000 shares were held at the Depository Trust Company. The Company anticipates that by December 10, 2026, the remaining 20,000,000 unrestricted shares should be deposited with DTC.
Through its sponsoring broker-dealer, Glendale Securities, the Company intends to request approval from OTC Markets Group to admit its Common Stock on OTCQB on a conditional basis. Any conditional admission requires the stock to meet the bid price requirement for 30 consecutive calendar days following admission. The Company also disclosed that it is developing a next-generation Raisewise Crowdfunding platform, which it plans to operate through its wholly or majority-owned subsidiaries in the U.S., Sweden, Morocco, and Brazil.
